GOVX: Rega marang dodolan GeoVax Labs
GeoVax Labs, Inc. (GOVX) is optimizing costs by outsourcing clinical trials to external CRO partners. The price-to-sales ratio on the GURU.Markets terminal chart reflects current dynamics, where the 4.60 mark indicates the level of business resilience. The company's prospects are based on its proprietary MVA platform for oncology, while stability is ensured by government support for immunotherapy development in US laboratories.
GeoVax Labs Inc (GOVX) - rincian metrik lan laporan keuangan
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Utang marang Modal GeoVax Labs, Inc.|GOVX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas GeoVax Corp|GOVX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku GeoVax Labs Inc|GOVX - Kewajiban jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan GeoVax|Rasio jangkoan perantara geovax.com
- rincian bathi lan kelipatan pasar:
GOVX - Bathi resik perusahaan|Bathi sing dikarepake GeoVax Labs, Inc.|GOVX - Pangali P/E|Pangali Forward P/E GeoVax Labs|GOVX - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan GeoVax Labs Inc|GOVX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan GeoVax|GOVX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan geovax.com|GOVX - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep GeoVax Labs, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:GOVX geovax.com
The P/S ratio determines the market value of a business relative to its annual revenue, allowing for an assessment of the asset's overvaluation. Investors utilize this metric to identify entry points while considering the risks of sales stagnation. Analyzing the price-to-sales ratio for GeoVax Labs, Inc. (GOVX) is critical, as fixed R&D costs create potential for explosive profit growth when scaling production through outsourcing.
Karo sapa GeoVax Labs, Inc. saingan
argenx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (BioNTech)|Abivax Pharma (ABVX) - Rega marang dodolan|ADMA Bio - Multiplikator P/S|Multiplikator rega marang pendapatan Protagonist Corp (PTGX)|IMVT: Multiplikator P/S|Rega marang dodolan kiniksa.com (KNSA)|Rasio rega marang pendapatan Grifols|Rega marang dodolan Adaptive Biotech ADPT|Kapitalisasi marang pendapatan CLDX (Celldex)|Rasio rega marang pendapatan AUPH (Aurinia Corp)|Multiplikator P/S BCRX (BioCryst)|Multiplikator P/S veratx.com VERA|DNTH: Kapitalisasi marang pendapatan|PHVS (Pharvaris NV) - Rasio kapitalisasi marang pendapatan|ABCL (AbCellera Biologics Inc) - Kapitalisasi marang pendapatan|Tourmaline - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Precigen, Inc.|Rasio rega marang pendapatan PHAR|Multiplikator P/S NKTR|Multiplikator P/S Upstream Bio, Inc. (UPB)|Multiplikator P/S ZBIO (Zenas Biopharma, Inc.)|Immunome Bio - Rasio rega marang pendapatan|GOSS - Rasio rega marang pendapatan|Koefisien rega marang pendapatan kalvista.com KALV|SEPN (Septerna) - Kapitalisasi marang pendapatan|Pieris Pharma - Rasio kapitalisasi pasar marang pendapatan|SVRA (Savara Corp) - Multiplikator P/S|Rigel Corp (RIGL) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan AnaptysBio, Inc. (ANAB)|astriatx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S ENGN (enGene)|RAPT - Kapitalisasi marang pendapatan|JBIO: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Aclaris Therapeutics, Inc ACRS|KYTX: Multiplikator P/S|Multiplikator rega marang pendapatan tizianalifesciences.com TLSA|Rasio rega marang pendapatan Cabaletta Bio|Rega marang dodolan Ventyx Biosciences Inc. VTYX|Kapitalisasi marang pendapatan THTX (Theratechnologies Inc)|Rasio rega marang pendapatan AVTX (Avalo Therapeutics Inc)|Eledon Pharmaceuticals - Kapitalisasi marang pendapatan|AGEN: Rasio kapitalisasi marang pendapatan|CLYM - Rasio rega marang pendapatan|Rasio rega marang dodolan ZURA|ATYR: Multiplikator P/S|Adagene Inc. - Rasio kapitalisasi pasar marang pendapatan|IMA (ImageneBio) - Multiplikator P/S|Multiplikator P/S Shattuck Therapeutics|Rasio rega marang pendapatan Equillium, Inc. (EQ)|CNTB (connectbiopharm.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Immunic IMUX|ATRA - Kapitalisasi marang pendapatan|InflaRx GmbH - Multiplikator P/S|XFOR - Multiplikator P/S|ACET (adicetbio.com) - Kapitalisasi marang pendapatan|Celularity - Rasio kapitalisasi pasar marang pendapatan|INMB (INmune Bio Corp) - Multiplikator P/S|Barinthus Biotherapeutics Corp (BRNS) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Kezar Life Sciences (KZR)|Kapitalisasi marang pendapatan sabbiotherapeutics.com SABS|Rasio rega marang pendapatan Akari Therapeutics Plc AKTX|ENLV - Kapitalisasi marang pendapatan|QTTB: Kapitalisasi marang pendapatan|EDSA - Multiplikator P/S|iBio, Inc. (IBIO) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan CARM|XTLB (XTL Biopharmaceuticals Ltd.) - Multiplikator P/S|Rega marang dodolan Bolt Bio BOLT|Multiplikator P/S HCWB|aptevotherapeutics.com (APVO) - Multiplikator rega marang pendapatan|Multiplikator P/S AIM (AIM ImmunoTech Inc.)|Aditxt Inc. (ADTX) - Rega marang dodolan|GRI - Rasio rega marang pendapatan|Rega marang dodolan XORTX Therapeutics Inc|HIND (ReShape Lifesciences) - Kapitalisasi marang pendapatan|REVB (Revelation Biosciences Corp) - Rasio rega marang pendapatan|INDP (Indaptus Therapeutics) - Multiplikator P/S|Multiplikator P/S scinai.com|Kapitalisasi marang pendapatan CALI (CalciMedica, Inc.)|affimed.com - Rasio kapitalisasi marang pendapatan|Allakos - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan HOOK|IGMS - Rasio rega marang pendapatan|ITOS: Rasio rega marang pendapatan|OCEA: Multiplikator P/S|TC BioPharm (Holdings) Plc (TCBP) - Multiplikator P/S|THRD (Third Harmonic Bio, Inc) - Multiplikator P/S
